Artal Group S.A.
An institutional investment manager in LUXEMBOURG. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 1053906.
- Reported value$931.1m
- Positions2
Holdings: 2 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Cava Group IncCAVA | COM | 148929102 | 511 | 54.9% | 6,507,990 | Reduced−3,000,000 | |
| Lexicon Pharmaceuticals IncLXRX | COM NEW | 528872302 | 420 | 45.1% | 175,156,062 | Added+20,421,735 |
Source: SEC EDGAR, Form 13F-HR, accession 0001053906-26-000008 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.